10.1111/obr.13112 49
dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)

Foods most consistently associated with higher GLP-1 include legumes (lentils, chickpeas), oats and barley, cooked-and-cooled rice or potatoes (higher resistant starch), green (unripe) banana, high-quality protein sources such as whey, eggs, fish and poultry, and fermented dairy like yogurt and kefir
Clinically Approved Standard by Dial A Vet Veterinary Team Disclaimer: The customer and expert messages presented herein may have been altered with artificial intelligence or modified to enhance readability and safeguard the privacy of individuals
The key structural modification is a C18 fatty diacid chain attached at position 26 (lysine) via a linker, which enables non-covalent binding to albumin in the bloodstream